Tag: humanized/therapeutic use

Influence factors and strategies of anti-VEGF therapy for wet AMD

Authors: Dai Hong,  Lu Yingyi DOI: 10.3760/cma.j.issn.2095-0160.2016.01.001 Published 2016-01-10 Cite as Chin J Exp Ophthalmol, 2016,34(1): 1-4. Abstract                            [Download PDF] [Read Full Text] Neovascular age-related macular degeneration is also known as wet age-related macular degeneration (wAMD), which is now one of potentially blinding diseases in elder population worldwide.The […]

Macular choroidal thickness changes following intravitreal injection of ranibizumab for central retinal vein occlusion

Authors: Du Yuqin,  Han Mei,  Xie Shiyong,  Wang Ying,  Li Yan DOI: 10.3760/cma.j.issn.2095-0160.2016.01.016 Published 2016-01-10 Cite as Chin J Exp Ophthalmol, 2016,34(1): 72-77. Abstract                              [Download PDF] [Read Full Text] Background Central retinal vein occlusion (CRVO) is a common retinal vascular disease.Intravitreal injection of ranibizumab, a vascular endothelial growth factor (VEGF) […]

A comparative study on conbercept and triamcinolone acetoinde intravitreal injection for macular edema secondary to central retinal vein occlusion

Authors: Ma Fengwei,  Du Cuiyun,  Cheng Meihong,  Ma Yusheng DOI: 10.3760/cma.j.issn.2095-0160.2016.09.013 Published 2016-09-10 Cite as Chin J Exp Ophthalmol, 2016,34(9): 837-841. Abstract                               [Download PDF] [Read Full Text] Background Macular edema is one of the serious complications of central retinal vein occlusion (CRVO), and the present therapies are laser coagulation […]

Preventive effect of intravitreal injection of ranibizumab on rehaemorrhagia following vitrectomy for prolifarative diabetic retinopathy

Authors: Ma Lie,  Li Xiaoxin DOI: 10.3760/cma.j.issn.2095-0160.2017.01.014 Published 2017-01-10 Cite as Chin J Exp Ophthalmol, 2017,35(1): 69-72. Abstract                              [Download PDF] [Read Full Text] Background Vitrectomy is a primary approach to the treatment of proliferative diabetic retinopathy (PDR). However, postoperative rehaemorrhagia often occur.Ranibizumab is […]

Influence of repetitive intravitreal ranibizumab for neovascular age-related macular degeneration on retinal pigment epithelium and choroidal thickness

Authors: Qi Hang,  Chen Changzheng,  Su Yu,  Yi Zuohuizi DOI: 10.3760/cma.j.issn.2095-0160.2017.10.012 Published 2017-10-10 Cite as Chin J Exp Ophthalmol, 2017,35(10): 909-913. Abstract                               [Download PDF] [Read Full Text] Background Intravitreal injection of ranibizumab (IVR) is one of the most effective therapies for neovascular age-related macular degeneration (nAMD). Understanding the influence […]